GKB Ophthalmics Ltd - Stock Valuation and Financial Performance

BSE: 533212 | NSE: GKB | Medical Equipment/Supplies/Accessories | Small Cap

GKB Ophthalmics Share Price

88 -0.94 -1.06%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on GKB Ophthalmics

M-Cap below 100cr DeciZen not available

GKB Ophthalmics stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
44 Cr.
52-wk low:
74.1
52-wk high:
128

Is GKB Ophthalmics Ltd an attractive stock to invest in?

1. Is GKB Ophthalmics Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that GKB Ophthalmics Ltd is a below average quality company.

2. Is GKB Ophthalmics Ltd undervalued or overvalued?

The key valuation ratios of GKB Ophthalmics Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is GKB Ophthalmics Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of GKB Ophthalmics Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of GKB Ophthalmics:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
GKB Ophthalmics Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 8.1%-4.3%-0.4%-1.5%-4.9%-6.8%-7.5%-1.2%-3.3%-4.8%-
Value Creation
Index
-0.4-1.3-1.0-1.1-1.4-1.5-1.5-1.1-1.2-1.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 31.429.931.238.336.930.525.621.327.127.730
Sales YoY Gr.--4.9%4.4%22.9%-3.7%-17.5%-16.1%-16.5%26.8%2.5%-
Adj EPS 1.3-7-3-3.4-6.4-8.1-8.5-2.9-4.7-5.9-8.3
YoY Gr.--633.3%NANANANANANANANA-
BVPS (₹) 43.336.869.771.264.968.569.96560.354.650.5
Adj Net
Profit
0.6-2.9-1.2-1.4-2.7-3.8-4.3-1.5-2.4-3-4
Cash Flow from Ops. 5.55.9-11.9-4.2-3.75.36.12.12.3-1.1-
Debt/CF from Ops. 2.31.5-0.6-1.7-2.71.91.65.75-9.8-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -1.4%-5.6%2.8%2.5%
Adj EPS -218.1%NANANA
BVPS2.6%-3.4%-7.9%-9.5%
Share Price 11.7% -1% 1.9% -16.1%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
3.1-17.6-5.6-4.9-9.4-12.2-12.3-4.3-7.4-10.3-15.7
Op. Profit
Mgn %
18.5-2.6-7.8-1.1-2.7-3.3-2.9-1.3-1.5-4-4.6
Net Profit
Mgn %
1.8-9.8-4-3.7-7.2-12.3-16.8-6.9-8.7-10.8-13.7
Debt to
Equity
0.70.60.30.20.40.30.30.40.40.4-
Working Cap
Days
35635329723627532835538328725890
Cash Conv.
Cycle
2251971601481821901281449078-32

Recent Performance Summary

No data to display

Return on Equity is Poor

Sales growth has been subdued in last 3 years 2.75%

Sales growth is not so good in last 4 quarters at 7.96%

Latest Financials - GKB Ophthalmics Ltd.

Standalone Consolidated
TTM EPS (₹) -8.3 -7.6
TTM Sales (₹ Cr.) 30.3 86.7
BVPS (₹.) 50.5 120.4
Reserves (₹ Cr.) 20 56
P/BV 1.73 0.72
PE 0.00 0.00
From the Market
52 Week Low / High (₹) 74.10 / 127.95
All Time Low / High (₹) 12.25 / 209.20
Market Cap (₹ Cr.) 44
Equity (₹ Cr.) 5
Face Value (₹) 10
Industry PE 59.3

Management X-Ray of GKB Ophthalmics:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of GKB Ophthalmics

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales31.3829.8531.1738.3236.9230.4725.5621.3427.0527.73
Operating Expenses 25.5930.6334.6538.7737.9031.5226.2921.9227.4928.83
Manufacturing Costs5.216.797.589.308.076.165.514.805.126.18
Material Costs13.9415.8717.9420.7220.381612.869.9213.7513.67
Employee Cost 4.836.256.227.077.427.566.215.816.927.45
Other Costs 1.611.712.921.672.041.801.711.391.701.52
Operating Profit 5.79-0.78-3.48-0.45-0.99-1.05-0.73-0.57-0.45-1.10
Operating Profit Margin (%) 18.4%-2.6%-11.2%-1.2%-2.7%-3.5%-2.9%-2.7%-1.7%-4.0%
Other Income 0.811.212.311.471.052.621.383.341.962.09
Interest 2.862.491.611.261.231.391.351.341.341.50
Depreciation 1.181.481.421.341.583.433.472.992.492.54
Exceptional Items 0.380.5121.822.70000-0.7200
Profit Before Tax 2.94-3.0317.611.12-2.74-3.25-4.17-2.29-2.31-3.04
Tax 2.11-0.773.950.36-0.17-0.480-0.180-0.16
Profit After Tax 0.83-2.2613.660.76-2.58-2.78-4.17-2.11-2.31-2.88
PAT Margin (%) 2.6%-7.6%43.8%2.0%-7.0%-9.1%-16.3%-9.9%-8.5%-10.4%
Adjusted EPS (₹)2.0-5.432.91.8-6.2-6.0-8.3-4.2-4.6-5.7
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 17.9915.3028.9629.5926.9431.7735.2532.7730.4027.52
Share Capital 4.154.154.154.154.154.645.045.045.045.04
Reserves 13.8411.1424.8025.4422.7827.1330.2127.7325.3622.48
Minority Interest0000000000
Debt11.357.587.157.129.8810.049.9911.3211.2410.82
Long Term Debt1.520.480.130.070.020011.621.17
Short Term Debt9.827.107.027.059.8610.049.9910.329.629.65
Trade Payables8.8715.775.886.064.777.517.856.825.985.21
Others Liabilities 12.4510.065.557.983.839.597.339.6910.019.34
Total Liabilities 50.6548.7147.5450.7445.4258.9060.4260.6057.6352.89

Fixed Assets

Gross Block26.6526.8328.3233.0134.7645.2549.2242.3543.1741.58
Accumulated Depreciation13.0415.1115.8316.5717.7920.9624.3920.0721.9024.30
Net Fixed Assets13.6111.7212.4916.4316.9824.2924.8322.2821.2717.28
CWIP 0.570.570.570.570.24001.233.293.82
Investments 5.535.5310.453.770.660.323.2112.2211.9011.90
Inventories15.1415.2714.0216.0714.846.794.706.985.346.06
Trade Receivables15.1214.447.917.3510.4410.8110.377.4464.88
Cash Equivalents 0.360.500.720.750.396.6110.362.101.430.41
Others Assets0.320.671.385.801.8810.086.968.358.408.53
Total Assets 50.6548.7147.5450.7445.4258.9060.4260.6057.6352.89

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 5.475.87-11.90-4.20-3.715.316.132.112.33-1.14
PBT 2.94-3.0317.611.12-2.74-3.25-4.17-2.29-2.31-3.04
Adjustment 3.543.64-19.08-0.652.803.304.142.132.252.34
Changes in Working Capital 0.037.41-3.46-3.37-3.655.36.182.272.4-0.41
Tax Paid -1.04-2.15-6.97-1.30-0.12-0.03-0.010-0.01-0.04
Cash Flow From Investing Activity -0.660.1314.745.502.28-8.63-5.68-11.52-0.832.40
Capex -0.68-0.63-1.93-4.88-1.56-9.66-3.66-2.81-3.681.39
Net Investments -1.30015.869.383.110.35-0.02-0.7910.24
Others 1.320.770.8110.730.67-2-7.921.840.77
Cash Flow From Financing Activity -4.81-6-2.81-1.291.419.213.310.61-1.50-2.03
Net Proceeds from Shares 000007.554.65000
Net Proceeds from Borrowing -1.07-1.16-1.32-0.07-0.07-0.050.031.610.48-0.56
Interest Paid -2.23-2.12-1.42-1.26-1.23-1.37-1.33-1.32-1.28-1.49
Dividend Paid 0000000000
Others -1.51-2.73-0.080.032.713.08-0.040.33-0.700.03
Net Cash Flow 0.0100.020-0.025.883.76-8.800-0.78
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)4.73-13.5861.742.6-9.11-9.47-12.45-6.2-7.31-9.95
ROCE (%)18.48-1.9863.976.51-4.11-4.56-6.27-2.11-2.24-3.81
Asset Turnover Ratio0.630.640.690.830.780.580.430.350.460.5
PAT to CFO Conversion(x)6.59N/A-0.87-5.53N/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days16317112468871271511529172
Inventory Days185176162135151130821008375
Payable Days22628322010597140218270170149

GKB Ophthalmics Ltd Stock News

GKB Ophthalmics Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of GKB Ophthalmics on 28-Mar-2024 16:01 is ₹88.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of GKB Ophthalmics stood at ₹43.96.
The latest P/E ratio of GKB Ophthalmics as of 28-Mar-2024 16:01 is 0.00.
The latest P/B ratio of GKB Ophthalmics as of 28-Mar-2024 16:01 is 1.73.
The 52-week high of GKB Ophthalmics is ₹128.0 and the 52-week low is ₹74.10.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of GKB Ophthalmics is ₹30.29 ( Cr.) .

About GKB Ophthalmics Ltd

GKB Ophthalmics Limited is a public limited company domiciled in India and was incorporated on December 10, 1981 under the provisions of the Companies Act, 1956. Its registered and principal office of business is located at 16-A, Tivim Industrial Estate, Mapusa, Goa, India.

Business area of the company

The Company is engaged in the business of manufacturing and supply of semi - finished plastic lenses. It has manufacturing facilities at Tivim Industrial Estate, Mapusa - Goa.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.